Press Releases

Date Title and Summary Additional Formats
Toggle Summary "Nature Reviews Drug Discovery" Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata
Analysis Drawn from Medidata's PICAS Database Uncovers a Significant Increase in the Number of Distinct Procedures Impacting Both Trial Cost and Site and Patient Burden Drug Development Sponsors Can Use Data to Benchmark Against Organizational Practices and Help Optimize Protocol Design NEW YORK
Toggle Summary Akros Pharma Inc. and Medidata Commemorate 10-year Partnership with Platform Expansion Agreement
Innovative pharmaceutical company leverages Medidata Clinical Cloud ® to accelerate the delivery of new therapies to market NEW YORK --(BUSINESS WIRE)--Nov. 1, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced
Toggle Summary Allscripts President Lee Shapiro Joins Medidata Solutions Board of Directors
Global Clinical Trial Technology Company Attracts Key Leader in Healthcare IT NEW YORK --(BUSINESS WIRE)-- Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced the election of Lee Shapiro to its board of directors.
Toggle Summary Aris Global and Medidata Solutions Partner to Offer Integration of EDC and Safety Reporting
Solution Offers Instant Data Transfer from EDC to Pharmacovigilance & Safety System to Streamline Patient Adverse Event and Reaction Reporting
Toggle Summary Array BioPharma Selects Medidata Rave® as Enterprise-Wide Electronic Data Capture Solution
Company Chooses Medidata Due to Superior Product Functionality and Corporate Vision
Toggle Summary ASKLEP Joins Medidata Partner Program to Expand Clinical Trial Services in Asia Pacific
Japanese CRO Builds New Services Around Leading Cloud-Based Clinical Research Platform to Enhance Trials, Extend Phase I-IV Services NEW YORK & TOKYO --(BUSINESS WIRE)-- ASKLEP Inc. , a leading Tokyo -based provider of clinical research services, has joined the Medidata Solutions (NASDAQ: MDSO)
Toggle Summary Astellas Selects Medidata Solutions as its Standard for Electronic Clinical Trials
One of Japan’s Largest Pharmas Chooses Medidata for Expertise in Global Markets and Unique Feature Functionality, Including Paper Study and Multi-Lingual Capabilities
Toggle Summary Axcan Pharma Achieves Cost Savings with Medidata Rave
Specialty Pharma Takes EDC Implementation In-House to Further Increase Trial Efficiencies and Contain Costs
Toggle Summary Boehringer Ingelheim Selects Medidata Clinical Cloud® to Accelerate Innovation in Drug Development
Medidata's Cutting-Edge Technology Platform Will Enable Top-20 Global Pharma to Conduct Faster, More Accurate and More Cost-Effective Clinical Trials Selection of Medidata Underscores Boehringer Ingelheim's Commitment to Deploy Best-in-Class Technology to Power Groundbreaking Medical Advances NEW
Toggle Summary Bristol-Myers Squibb Selects Medidata Clinical Cloud® to Drive Drug Development and Business Transformation
Medidata's Technology Platform and Data Analytics Maximize Value of Clinical Data, Enhance Trial Design and Execution, and Enable More Agility in Drug Development NEW YORK --(BUSINESS WIRE)-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life

Investor Contact

Betsy Frank
Head of Investor Relations
+1 917 522 4620

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331